glp-1 news today october 9 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Weight Reduction with GLP-1 Agonists

#GLP1 receptor agonists are linked to a modest rise in biliary events in #Diabetes More gallstones/cholecystitis/cholecystectomy at 3 years No significant increase in pancreatitis or ERCP Absolute event rates remained low #OpenAccess bit.ly/4x0N5B0 #GLP1 receptor agonists are linked to a modest rise in biliary events in #Diabetes More gallstones/cholecystitis/cholecystectomy at 3 years No significant increase in pancreatitis or ERCP Absolute event rates remained low #OpenAccess bit.ly/4x0N5B0 This Post is unavailable

8 , 9 8 , 9 Weight Loss Medications 11 12 Other medications used off label to treat overweight/obesity include topiramate, zonisamide, bupropion, metformin, pramlintide, and the SGLT2 Inhibitors canagliflozin and dapagliflozin

Fewer options : Smaller businesses usually have to choose from a handful of pre-designed plans and can only offer one plan for all employees

GLP-1 medications are commonly used for weight loss and type-2 diabetes, and many of them are given as injections